read-out parameter. Apparently, G i proteins are not involved in the process because the ADP-ribosylating bacterial toxin pertussis toxin does not affect the process. Additionally, desensitization has no effect of β 3 AR expression density and affinity, arguing against the receptor itself being the target of desensitization. However, the direct AC activator forskolin effectively reduces β 3 AR-mediated cAMP accumulation, and conversely, β 3 AR-agonist stimulation effectively reduces forskolin-mediated cAMP accumulation. These data strongly suggest that ACs are the target of β 3 AR-mediated desensitization.
This paper raises several questions. It is puzzling why β 3 AR desensitization is so cell type-specific. As a first step, the expression pattern of AC isoforms in HEK-and CHO cells has to be studied. Such studies are straightforward at the mRNA level (Kinast et al. 2012) but highly problematic at the protein level because of the questionable quality of AC antibodies (Göttle et al. 2009 ). Should there be an AC isoform that is expressed exclusively in HEK cells but not in CHO cells, then the corresponding AC isoform could be knocked down with the siRNA technique. Conversely, expression of a defined AC isoform in CHO cells may reconstitute desensitization of the β 3 AR in these cells. Unfortunately, there is a paucity of isoform-specific and cell membrane-permeable AC inhibitors that could complement such genetically oriented studies .
Another question is how β 3 AR agonists and forskolin induce desensitization. Formally, it is possible that the effect of β 3 AR agonists is mediated via cAMP-dependent or cAMP-independent mechanisms. Accordingly, the effects of other cAMP-elevating compounds such as phosphodiesterase inhibitors and membrane-permeable cAMP analogs should be studied. Moreover, the effects of inhibitors of cAMP-dependent protein kinase (PKA) should be examined. In fact, it has already been shown that at least in adipocytes, the β 3 AR can activate both PKA-dependent and PKA-independent signal transduction pathways (Tchivileva et al. 2009 ). While the involvement of G i mediated signaling seems unlikely in the desensitization, non-canonical G qand/or β-arrestin-mediated signal transduction should be considered too (Reiter et al. 2012) .
Conversely, the precise mechanism by which forskolin induces desensitization of the β 3 AR is still unknown. While forskolin is an activator of AC isoforms 1-8 , the diterpene can also exert off-target effects on other proteins (Laurenza et al. 1989 ). An approach to discriminate between AC-dependent and AC-independent effects of forskolin is to conduct structure-activity relationship studies for diterpenes, 1-deoxy forskolin analogs being without stimulatory effect on ACs (Laurenza et al. 1989; . Along the same line, the effects of PKA inhibitors on forskolin-induced desensitization have to be studied. Furthermore, it remains to be determined whether desensitization takes place directly at the level of AC or indirectly at a protein interacting with AC (Ostrom et al. 2012; Scott et al. 2013) . Most importantly, once the molecular mechanisms of β 3 AR desensitization have been worked out in mammalian expression systems, this process should also be studied in human detrusor muscle samples in order to determine the clinical relevance of the intriguing observation in the paper by Michel-Reher and Michel.
